MUTAGENICITY OF NITROBENZYL DERIVATIVES - POTENTIAL BIOREDUCTIVE ANTICANCER AGENTS

Citation
Tr. Juneja et al., MUTAGENICITY OF NITROBENZYL DERIVATIVES - POTENTIAL BIOREDUCTIVE ANTICANCER AGENTS, Mutation research. Mutation research letters, 348(3), 1995, pp. 137-145
Citations number
43
Categorie Soggetti
Genetics & Heredity",Toxicology
ISSN journal
01657992
Volume
348
Issue
3
Year of publication
1995
Pages
137 - 145
Database
ISI
SICI code
0165-7992(1995)348:3<137:MOND-P>2.0.ZU;2-A
Abstract
Ortho-, meta- and para-nitrobenzyl bromides, alcohols, ethers and este rs were synthesised and tested for their mutagenicity toward Salmonell a typhimurium TA100, TA100NR (nitroreductase deficient) and TA98 in ab sence of S9 mix and in TA100 with S9 mix. Compounds of the ortho- and meta-series were non mutagenic with and without S9 mix. Except for the alcohol and ether, the compounds of the pam-series were mutagenic in TA100 with activity sequence propionate > butyrate > benzoate > acetat e > bromide and this specific activity was reduced considerably by S9 mix. The Ames Salmonella test system does not seem to be an appropriat e model to evaluate mutagenicity of o-nitrobenzyls. However, further w ork is in progress to test all the compounds fbr mutagenicity in mamma lian system.